Primary |
Drug Use For Unknown Indication |
27.4% |
Muscle Spasms |
10.8% |
Product Used For Unknown Indication |
10.1% |
Back Pain |
8.0% |
Depression |
6.8% |
Pain |
6.8% |
Drug Exposure During Pregnancy |
4.9% |
Hypertension |
4.2% |
Anxiety |
4.0% |
Fibromyalgia |
3.2% |
Insomnia |
2.3% |
Myalgia |
2.1% |
Schizophrenia |
1.5% |
Ill-defined Disorder |
1.3% |
Multiple Sclerosis |
1.3% |
Urinary Tract Infection |
1.3% |
Back Disorder |
1.1% |
Contraception |
1.1% |
Muscle Relaxant Therapy |
1.1% |
Nausea |
1.1% |
|
Drug Abuse |
7.2% |
Retained Placenta Or Membranes |
7.2% |
Overdose |
5.8% |
Somnolence |
5.8% |
Spina Bifida |
5.8% |
Suicide Attempt |
5.8% |
Unresponsive To Stimuli |
5.8% |
Urinary Tract Infection |
5.8% |
Weight Increased |
5.8% |
Drug Interaction |
4.3% |
Medication Error |
4.3% |
Mental Status Changes |
4.3% |
Myocardial Infarction |
4.3% |
Pain |
4.3% |
Pain In Extremity |
4.3% |
Suicidal Ideation |
4.3% |
Syncope |
4.3% |
Tachycardia |
4.3% |
Cardiac Arrest |
2.9% |
Confusional State |
2.9% |
|
Secondary |
Product Used For Unknown Indication |
18.7% |
Pain |
14.0% |
Drug Use For Unknown Indication |
8.6% |
Muscle Spasms |
7.6% |
Depression |
6.2% |
Foetal Exposure During Pregnancy |
5.6% |
Back Pain |
5.5% |
Fibromyalgia |
5.4% |
Multiple Sclerosis |
3.5% |
Drug Exposure During Pregnancy |
3.3% |
Arthralgia |
3.0% |
Hypertension |
2.8% |
Neuralgia |
2.5% |
Anxiety |
2.5% |
Ill-defined Disorder |
2.3% |
Contraception |
2.0% |
Drug Exposure In Utero |
1.8% |
Retroperitoneal Fibrosis |
1.6% |
Gastrooesophageal Reflux Disease |
1.5% |
Pain In Extremity |
1.5% |
|
Drug Hypersensitivity |
17.1% |
Wrong Technique In Drug Usage Process |
9.3% |
Somnolence |
6.9% |
Spina Bifida |
6.9% |
Weight Increased |
6.9% |
Pain |
6.5% |
Suicide Attempt |
6.5% |
Drug Ineffective |
4.6% |
Vomiting |
4.2% |
Hypothyroidism |
3.7% |
Overdose |
3.7% |
Talipes |
3.7% |
Drug Withdrawal Syndrome Neonatal |
3.2% |
Urinary Tract Infection |
2.8% |
Loss Of Consciousness |
2.3% |
Memory Impairment |
2.3% |
Pulmonary Embolism |
2.3% |
Retained Placenta Or Membranes |
2.3% |
Rhabdomyolysis |
2.3% |
Sedation |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
25.5% |
Pain |
11.5% |
Drug Use For Unknown Indication |
10.1% |
Depression |
5.7% |
Rheumatoid Arthritis |
4.8% |
Hypertension |
4.7% |
Anxiety |
4.0% |
Muscle Spasms |
4.0% |
Back Pain |
3.9% |
Fibromyalgia |
3.5% |
Gastrooesophageal Reflux Disease |
3.3% |
Osteoporosis |
2.6% |
Multiple Sclerosis |
2.5% |
Asthma |
2.3% |
Insomnia |
2.3% |
Diabetes Mellitus |
2.0% |
Migraine |
1.9% |
Sleep Disorder |
1.9% |
Arthritis |
1.9% |
Crohn's Disease |
1.8% |
|
Vomiting |
12.1% |
Weight Increased |
11.5% |
Weight Decreased |
9.4% |
Pain |
7.7% |
Pulmonary Embolism |
6.2% |
Vision Blurred |
4.9% |
Type 2 Diabetes Mellitus |
4.7% |
Urinary Tract Infection |
4.6% |
Nausea |
4.3% |
Wrong Technique In Drug Usage Process |
4.2% |
Drug Ineffective |
4.1% |
Pain In Extremity |
3.6% |
Deep Vein Thrombosis |
3.4% |
Pneumonia |
3.2% |
Rash |
2.9% |
Suicidal Ideation |
2.8% |
Injection Site Pain |
2.6% |
Withdrawal Syndrome |
2.6% |
White Blood Cell Count Increased |
2.6% |
Death |
2.5% |
|
Interacting |
Pain |
20.5% |
Product Used For Unknown Indication |
17.8% |
Analgesic Therapy |
13.7% |
Smoking Cessation Therapy |
12.3% |
Fall |
8.2% |
Muscle Spasms |
4.1% |
Fibromyalgia |
2.7% |
Insomnia |
2.7% |
Lung Disorder |
2.7% |
Breakthrough Pain |
1.4% |
Depression |
1.4% |
Gastrooesophageal Reflux Disease |
1.4% |
Hypertension |
1.4% |
Hypoaesthesia |
1.4% |
Hypotonia |
1.4% |
Ill-defined Disorder |
1.4% |
Inflammation |
1.4% |
Muscle Disorder |
1.4% |
Muscle Relaxant Therapy |
1.4% |
Narcolepsy |
1.4% |
|
Drug Interaction |
17.4% |
Hypothyroidism |
17.4% |
Sleep Walking |
8.7% |
Toothache |
8.7% |
Violence-related Symptom |
8.7% |
Weight Increased |
8.7% |
Drug Dose Omission |
4.3% |
Fatigue |
4.3% |
Injury |
4.3% |
Nightmare |
4.3% |
Pain In Extremity |
4.3% |
Road Traffic Accident |
4.3% |
Wrong Technique In Drug Usage Process |
4.3% |
|